A 6-year-old child with β-thalassemia major is scheduled for regular blood transfusions. Which nursing intervention is the priority before administering the blood transfusion?

Patient safety is the highest priority in blood transfusion administration. Proper patient identification and blood compatibility verification prevent potentially fatal transfusion reactions.

Transfusion safety requires meticulous attention to patient identification and blood product verification, and is essential to prevent potentially fatal hemolytic transfusion reactions. The most critical nursing intervention before any transfusion is proper patient identification using two patient identifiers (such as name and date of birth) and blood compatibility verification through cross-checking with another qualified nurse.

Children with β-thalassemia major require regular blood transfusions every 2-4 weeks to maintain adequate hemoglobin levels and prevent complications such as growth retardation, bone deformities, and organ dysfunction. These patients are at particularly high risk for transfusion reactions due to the potential development of alloimmunization from frequent exposure to blood products.

The verification process should include matching the patient's identification band with the blood bank label, confirming ABO and Rh compatibility, verifying the unit number and expiration date, and ensuring the blood product appears normal without clots, discoloration, or hemolysis. The double-check system with another nurse serves as a critical safety measure to prevent administration errors.

While premedication may be used in some cases, it is not universally necessary and should not take precedence over proper identification. Monitoring urine output during transfusion is important but is not the priority before initiation. Blood should be transfused slowly (1-2 mL/kg/hr) for the first 15 minutes to monitor for reactions, as a rapid rate increases the risk of reactions.

Understanding the Priority in Pediatric Transfusion for Beta-Thalassemia Major

A 6-year-old child with β-thalassemia major requires chronic transfusion therapy to maintain hemoglobin levels and suppress ineffective erythropoiesis. Before any blood product is administered, the most critical step is ensuring the correct blood component is given to the correct patient. A failure at this stage leads to an acute hemolytic transfusion reaction, a life-threatening event caused by ABO incompatibility.

The priority intervention is to verify the child's identity and blood compatibility using two patient identifiers and cross-check with another qualified nurse. This double-check process serves as the primary barrier against clerical errors, which are the leading cause of fatal transfusion reactions. The educational manual developed by Soares et al. (2026) emphasizes that structured, validated educational technologies are essential for nursing care in blood transfusion because the procedure is high-risk and requires meticulous attention to safety protocols . The act of two qualified professionals independently verifying the patient's wristband, the blood unit tag, and the compatibility report at the bedside directly addresses this high-risk nature. A nationwide study analyzing pretransfusion testing data further underscores the importance of these processes, noting that proper pretransfusion testing, including crossmatching, is a fundamental safety net analyzed across all hospital types to prevent adverse events .

Analyzing the Incorrect Options

Administering premedication with acetaminophen (Option 2) is a common but not universally required practice. While it may be ordered to prevent febrile nonhemolytic transfusion reactions in patients with a history of such reactions, it does not prevent the most dangerous immunologic complications. It is not a safety priority that overrides the identification and compatibility check.

Ensuring the child has voided recently (Option 3) is not a standard pretransfusion requirement. Monitoring for hemoglobinuria, a sign of an acute hemolytic reaction, is a critical nursing responsibility during and after the transfusion, but it is not a preparatory intervention that takes precedence over verifying the right patient and right blood product.

Starting the transfusion at a rapid rate (Option 4) is contraindicated. For pediatric patients, transfusions are typically initiated at a slower rate (e.g., 2-5 mL/kg/hr) for the first 15 minutes to observe for any immediate adverse reactions. Rapid infusion, especially in a child with chronic anemia, can precipitate volume overload and does not address the primary safety concern of misidentification. Training programs for nurses and midwives consistently highlight that critical nursing responsibilities during transfusion focus on strict adherence to protocols that prevent serious complications, starting with patient and product verification . A structured, competency-based approach to transfusion training, such as the BOPPPS model, reinforces that the initial steps of a high-stakes procedure like transfusion must be standardized to close persistent educational gaps and ensure patient safety .